When do biologic drug patents expire and when will biosimilars launch?

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Patent Expiration
Merck Sharp & Dohme Corp.	RECOMBIVAX, RECOMBIVAX HB	hepatitis b vaccine (recombinant)	Injection	101066	1986-07-23	⤷ Subscribe	⤷ Subscribe
Merck Sharp & Dohme Corp.	PNEUMOVAX 23	pneumococcal vaccine, polyvalent	Injection	101094	1977-11-21	⤷ Subscribe	⤷ Subscribe
Massbiologics	TDVAX	tetanus and diphtheria toxoids adsorbed	Injection	101322	1970-07-27	⤷ Subscribe	⤷ Subscribe
Sanofi Pasteur Limited	TENIVAC	tetanus and diphtheria toxoids adsorbed	Injection	103171	2003-11-03	⤷ Subscribe	⤷ Subscribe
Merck Sharp & Dohme Corp.	PEDVAXHIB	haemophilus b conjugate vaccine (meningococcal protein conjugate)	Injection	103237	1989-12-20	⤷ Subscribe	⤷ Subscribe
Glaxosmithkline Biologicals	HAVRIX	hepatitis a vaccine inactivated	Injection	103475	1995-02-22	⤷ Subscribe	⤷ Subscribe
Merck Sharp & Dohme Corp.	VAQTA	hepatitis a vaccine inactivated	Injection	103606	1996-03-29	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Patent Expiration